zepbound and semaglutide vs. Wegovy: Which Weight Loss Treatment Comes Out on Top? GLP-1 Updates: semaglutide / tirzepatide

By activating this hormone, semaglutide increases feelings of fullness and reduces feelings of hunger, leading to a lower calorie intake

We also do not carry medications that have the potential to be drugs of abuse

GLP-1 binds the GLP-1 receptor, which is found in the pancreas, stomach, and brain

Lowered A1C of 1.7%2.0% across doses Weight loss of 16.8% in the highest dose over 40 weeks without evidence of weight loss plateau The longer duration 80-week TRIUMPH-2 will more effectively evaluate the weight loss potential of retatrutide in those with type 2 diabetes and obesity, expected to result later this year Press release: To view or add a comment, sign in More Relevant Posts The FDA has approved Wegovy HD (semaglutide 7.2 mg) for adults with obesity